latest news

Sophiris Bio Reports Fourth Quarter and Full Year 2013 Financial Results and Key Operational Highlights

SAN DIEGO & VANCOUVER, British Columbia --(BUSINESS WIRE)-- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms more»

recent events

Sophiris Investor Webcast: Review of Topsalysin Clinical Data
Jan 28, 2016 | 11:00am

upcoming events

There are no upcoming events at this time.

credible science. incredible therapeutics.